132 related articles for article (PubMed ID: 34532292)
21. Retraction: Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway.
Frontiers Editorial Office
Front Oncol; 2020; 10():714. PubMed ID: 32373542
[TBL] [Abstract][Full Text] [Related]
22. CXCL8 Promotes Glioma Progression by Activating the JAK/STAT1/HIF-1
Onco Targets Ther; 2023; 16():211-212. PubMed ID: 37013128
[TBL] [Abstract][Full Text] [Related]
23. Retraction: Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCϵ/PKCϵ Signaling Pathway.
Frontiers Editorial Office
Front Oncol; 2021; 11():707608. PubMed ID: 34136414
[TBL] [Abstract][Full Text] [Related]
24. Retraction: Ppm1b Negatively Regulates 3-Bromopyruvic Acid Induced Necroptosis in Breast Cancer Cells.
Frontiers Editorial Office
Front Oncol; 2021; 11():757083. PubMed ID: 34513719
[TBL] [Abstract][Full Text] [Related]
25. Retraction: ECT2 Increases the Stability of EGFR and Tumorigenicity by Inhibiting Grb2 Ubiquitination in Pancreatic Cancer.
Frontiers Editorial Office
Front Oncol; 2021; 11():734761. PubMed ID: 34350126
[TBL] [Abstract][Full Text] [Related]
26. Retraction: MicroRNA-326 functions as a tumor suppressor in breast cancer by targeting ErbB/PI3K signaling pathway.
Frontiers Editorial Office
Front Oncol; 2023; 13():1298871. PubMed ID: 37881488
[TBL] [Abstract][Full Text] [Related]
27. Retraction: Exosome-Delivered LncHEIH Promotes Gastric Cancer Progression by Upregulating EZH2 and Stimulating Methylation of the GSDME Promoter.
Front Cell Dev Biol; 2022; 10():896056. PubMed ID: 35399521
[TBL] [Abstract][Full Text] [Related]
28. Retraction: A novel tumor suppressor gene, ZFN24, inhibits the development of NSCLC by inhibiting the Wnt signaling pathway to induce cell senescence.
Frontiers Editorial Office
Front Oncol; 2022; 12():1045516. PubMed ID: 36237304
[TBL] [Abstract][Full Text] [Related]
29. Retraction: Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1.
Frontiers Editorial Office
Front Oncol; 2021; 11():839904. PubMed ID: 35036357
[TBL] [Abstract][Full Text] [Related]
30. Retraction: LINC00337 Regulates KLF5 and Maintains Stem-Cell Like Traits of Cervical Cancer Cells by Modulating miR-145.
Frontiers Editorial Office
Front Oncol; 2021; 11():840051. PubMed ID: 35036358
[TBL] [Abstract][Full Text] [Related]
31. Retraction: CDX2/mir-145-5p/SENP1 Pathways Affect LNCaP Cells Invasion and Migration.
Frontiers Editorial Office
Front Oncol; 2021; 11():744978. PubMed ID: 34490129
[TBL] [Abstract][Full Text] [Related]
32. Forkhead Box Protein A1 is a Prognostic Predictor and Promotes Tumor Growth of Gastric Cancer [Retraction].
Onco Targets Ther; 2022; 15():829-830. PubMed ID: 35936235
[TBL] [Abstract][Full Text] [Related]
33. Retraction: Akt inhibition enhanced the growth inhibition effect of low-dose heavy-ion radiation via the PI3K/Akt/P53 signaling pathway in C6 glioblastoma cells.
Frontiers Editorial Office
Front Oncol; 2023; 13():1205993. PubMed ID: 38486935
[TBL] [Abstract][Full Text] [Related]
34. Retraction: Corrigendum: CDX2/mir-145-5p/SENP1 Pathways Affect LNCaP Cells Invasion and Migration.
Frontiers Editorial Office
Front Oncol; 2021; 11():744980. PubMed ID: 34490130
[TBL] [Abstract][Full Text] [Related]
35. NPTX1 Promotes Metastasis via Integrin/FAK Signaling in Gastric Cancer [Retraction].
Cancer Manag Res; 2023; 15():1123-1124. PubMed ID: 37842129
[TBL] [Abstract][Full Text] [Related]
36. Retraction Note: Inhibition of hTERT Gene Expression by SilibininLoaded PLGA-PEG-Fe₃O₄ in T47D Breast Cancer Cell Line.
Ebrahimnezhad Z; Zarghami N; Keyhani M; Amirsaadat S; Akbarzadeh A; Rahmati M; Mohammad Taheri Z; Nejati-Koshki K
Bioimpacts; 2018; 8(4):321. PubMed ID: 30397586
[TBL] [Abstract][Full Text] [Related]
37. Retraction: The role of LINC00284 in the development of thyroid cancer
Frontiers Editorial Office
Front Oncol; 2023; 13():1209909. PubMed ID: 37182166
[TBL] [Abstract][Full Text] [Related]
38. Retraction: Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study.
Frontiers Editorial Office
Front Oncol; 2021; 11():709636. PubMed ID: 34178702
[TBL] [Abstract][Full Text] [Related]
39. Retraction: The oncolytic virus in cancer diagnosis and treatment.
Frontiers Editorial Office
Front Oncol; 2023; 13():1320477. PubMed ID: 38023159
[TBL] [Abstract][Full Text] [Related]
40. RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression.
Liu YB; Mei Y; Long J; Zhang Y; Hu DL; Zhou HH
J Exp Clin Cancer Res; 2018 Aug; 37(1):182. PubMed ID: 30075819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
